Abstract
Background and aims
Evidence is accumulating for a role of folate in the aetiology of colorectal cancer (CRC). The methylenetetrahydrofolate reductase (MTHFR) gene, involved in folate metabolism, is polymorphic in humans. Since it is unknown whether the MTHFR C677T and A1298C polymorphisms alter the risk for CRC, this was the aim of our study.
Materials and methods
Genomic DNA from 102 sporadic colorectal adenocarcinoma (SCA) patients and 300 controls was analyzed by polymerase chain reaction followed by restriction digestion for the polymorphisms analyses.
Results/findings
The frequencies of MTHFR C677T and A1298C genotypes were similar in patients and controls. Similar overall risks for disease were seen in individuals with the distinct MTHFR genotypes. However, an excess of the MTHFR 677TT and 677CT genotypes was seen in patients under 50 years, compared with patients at an older age (19.2 vs 13.1% and 61.6 vs 39.5%, respectively; P = 0.04). The differences were more prominent when the frequency of the 677TT plus 677CT genotype was seen in both group of patients (80.8 vs 52.6%, respectively; P = 0.01), and in younger patients compared to controls (80.8 vs 52.3%, P < 0.01). Individuals with the combined genotype had 3.82-fold (95% confidence interval, 1.41–10.42) increased risk of developing SCA under 50 years, compared with those harboring the wild-type genotype.
Interpretation/conclusion
These results suggest a role for the MTHFR 677TT plus 677CT genotype in increasing SCA diagnosed at a low age in southeastern Brazil, but additional studies with larger sample sizes should be carried out to clarify this issue.
Similar content being viewed by others
References
Kim Y-I (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66–88
Little J, Sharp L (2002) Colorectal neoplasia and genetic polymorphisms associated with folate metabolism. Eur J Cancer Prev 11:105–110
Pufulete M, Al-Ghnaniem R, Leather AJM, Appleby P, Gout S, Terry C, Emery PW, Sanders TAB (2003) Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 124:1240–1248
Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21:163–167
Eichholzer M, Lüthy F, Moser U, Fowler B (2001) Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly 131:539–549
Van Der Put NMJ, Gabreels F, Stevens EM, Smeitink JÁ, Trijbels FJ, Eskes TK, Van Den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk for neural-tube defects? Am J Hum Genet 62:1044–1051
Johnson WG (1999) DNA polymorphism-diet-cofactor-development hypothesis and the gene–teratogen model for schizophrenia and other developmental disorders. Am J Med Genet 88:311–323
Slaterry Ml, Poter JD, Samowitz W, Shaffer D, Leppert M (1999) Methylenetetrahydrofolate reductase, diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8:513–518
Ma J, Stampfer MJ, Artigas C, Hunter DJ, Fuchs C, Willet WC, Selhub J, Hennekens CH, Rozen R (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098–1102
Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM (1997) Thermolable variant of 5,10-methylene-tetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349:1591–1593
Friedman G, Goldschmidt N, Friedlander Y, Bem-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129:1656–1661
Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ (2002) Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contribution to risk of colorectal cancer. Pharmacogenetics 12:339–342
Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willet WC, Hunter DJ (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56:4862–4864
Chen J, Giovannucci EL, Hunter DJ (1999) MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene–environmental interactions in colorectal tumorigenesis. J Nutr 129:560S–564S
Park KS, Mok JW, Kim JC (1999) The 677C>T mutation in 5,10-methylene-tetrahydrofolate reductase and colorectal cancer risk. Genet Test 3:233–236
Delgado-Enciso I, Martinez-Garza SG, Rojas-Martinez A, Ortiz-Lopez R, Bosques-Padilla F, Calderon-Garciduenas AL, Zarate-Gomez M, Barrera-Saldana HÁ (2001) 677T mutation of the MTHFR gene in adenomas and colorectal cancer in a population sample from the northeastern Mexico (in Spanish). Rev Gastroenterol Mex 66:32–37
Keku T, Millikan R, Worley K, Winckel S, Eaton A, Martin C, Sandler R (2002) 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 11:1611–1621
Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A (2002) B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 13:239–248
Shannon B, Gnanasampanthan S, Beilby J, Lacopetta B (2002) A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 50:520–524
Sharp L, Little J, Brockton N (2002) Dietary intake of folate and related micronutrients, genetic polymorphisms in MTHFR and colorectal cancer: a population-based case control study in Scotland (Abstract). J Nutr 132:3542S
Toffoli G, Gafa R, Russo A, Lanza G, Dolcetti R, Sartor F, Libra M, Viel A, Boiocchi M (2003) Methylenetetrahydrofolate reductase 677C>T polymorphism and risk of proximal cancer in north Italy. Clin Cancer Res 9:743–748
Arruda VR, Grignolli CE, Gonçalves MS, Soares MC, Menezes R, Saad STO, Costa FF (1998) Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: relevance to environmental carcinogenesis? Clin Genet 54:210–214
Alves-Silva J, Da Silva-Santos M, Guimaraes PE, Ferreira AC, Bandelt HJ, Pena SD, Prado VF (2000) The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 67:444–461
Carvalho-Silva DR, Santos FR, Rocha J, Pena SD (2001) The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 68:281–286
Duncan BB, Schmidt MI, Polanczyk CA, Mengue SS (1992) High mortality rates among Brazilian adult populations: an international comparison. Rev Assoc Med Bras 38:138–144
Mattos LL, Martins IS (2000) Dietary fiber consumption in an adult population. Rev Saude Publica 34:50–55
Freedman NA, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Zhang Z-F, Black JD, Satchidanand S, Asirwatham JE (1996) The relationship between smoking exposure and p53 overexpression in colorectal cancer. Br J Cancer 73:902–908
Broders AC (1925) The grading of carcinoma. Minn Med 8:726–730
Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DJ, Morrow M (2002) Colon and rectum. In: Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DJ, Morrow M (eds) American joint committee on cancer-cancer staging manual. Springer, Berlin Heidelberg New York, pp 113–123
Astler VB, Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:846–851
Fosster P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Den Heijer M, Kluijtmans LA, Van Den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylene-tetrahydrofolate reductase. Nat Genet 10:111–113
Ioannidis JP, Ntazani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306–309
De Jong MM, Noite IM, Meerman GJ, Van Der Graaf WTA, Vries EGE, Sijmons RH, Hofstra RMW, Kleibeuker JH (2002) Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 11:1332–1352
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182
Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG, MTHFR Studies Collaboration Group (2002) MTHFR 677C→T polymorphism and risk of coronary heart disease. JAMA 288:2023–2031
Chen K, Jiang QT, He HQ (2005) Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 11:331–335
Sharp L, Little J (2004) Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a huge review. Am J Epidemiol 159:423–443
Bailey LB (2003) Folate, methyl-related nutrients, alcohol, and the MTHFR 677C>T polymorphism affect cancer risk: intake recommendations. J Nutr 133:3748S–3753S
Kim Y (1997) Folate deficiency in rats induces DNA strand breaks and hypomethylation with the p53 tumor suppressor gene. Am J Clin Nutr 65:46–52
Duthie SJ (1999) Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55:578–592
Kim Y, Giuliano AR, Hatch KD, Schneider A, Nour MA, Dallal GE (1994) Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 74:893–898
Fowler BM, Giuliano AR, Piyathilake C, Nour M, Hatch K (1998) Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev 7:901–906
Acknowledgements
The authors would like to thank Mr. Roberto Zulli for checking the statistical analysis and the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) for the financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lima, C.S.P., Nascimento, H., Bonadia, L.C. et al. Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. Int J Colorectal Dis 22, 757–763 (2007). https://doi.org/10.1007/s00384-006-0237-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-006-0237-z